419 related articles for article (PubMed ID: 29727401)
21. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
[TBL] [Abstract][Full Text] [Related]
22. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
Koiso T; Yamamoto M; Watanabe S; Barfod BE
Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
[TBL] [Abstract][Full Text] [Related]
23. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
[TBL] [Abstract][Full Text] [Related]
24. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
25. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
Cao Y; Huang DQ; Shih G; Prince MR
AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
[TBL] [Abstract][Full Text] [Related]
26. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
27. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
[TBL] [Abstract][Full Text] [Related]
28. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
Ichikawa S; Omiya Y; Onishi H; Motosugi U
J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
[TBL] [Abstract][Full Text] [Related]
29. Effect of Age on High T1 Signal Intensity of the Dentate Nucleus and Globus Pallidus in a Large Population Exposed to Gadodiamide.
Quattrocchi CC; Errante Y; Mallio CA; Marinelli L; LoVullo G; Giannotti G; Della Sala SW; van der Molen AJ; Beomonte Zobel B
Invest Radiol; 2018 Apr; 53(4):214-222. PubMed ID: 29166300
[TBL] [Abstract][Full Text] [Related]
30. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
31. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
32. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
[TBL] [Abstract][Full Text] [Related]
33. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
34. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
[TBL] [Abstract][Full Text] [Related]
35. Does renal function affect gadolinium deposition in the brain?
Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
[TBL] [Abstract][Full Text] [Related]
36. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Pozeg P; Forget J; Meuli RA; Maeder P
Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
[TBL] [Abstract][Full Text] [Related]
37. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
38. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
Flood TF; Stence NV; Maloney JA; Mirsky DM
Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
[TBL] [Abstract][Full Text] [Related]
39. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]